Saudi Arabia’s sovereign wealth fund is said to be in late-stage talks over an investment in British startup Babylon Health. The investment, which would come as part of a funding round worth hundreds of millions of dollars, could be announced later this week, the Financial Times reported, citing people with knowledge of the matter. Babylon’s
– Artis icono will integrate with VIST® Virtual Patient to offer a safe, immersive, and radiation-free endovascular procedure simulation environment inside the angio-suite – The combined solution will allow clinicians to explore new interventional methods prior to using on actual patients STOCKHOLM, June 24, 2019 — Siemens Healthineers, a leading medical technology company and Mentice AB, a
The unit will take forward digital transformation in the NHS, allowing patients and staff to benefit from the latest digital systems and technology. A new joint unit, NHSX, will be created to bring the benefits of modern technology to every patient and clinician. It will combine the best talent from government, the NHS and industry.
SELBYVILLE, Del., Feb. 5, 2019 — Germany dominated the Europe blockchain technology in the healthcare market and was valued at around USD 2.9 million in the year 2018. Various companies and cities in the country are turning into a development hub for blockchain technology. Several German firms are planning to integrate and implement blockchain technology due to increased automation, efficiency
This market insight highlights global healthcare trends and the GCC’s position in relation to these developments. It also assesses opportunities for technology providers with a focus on the penetration potential of key medical technologies. Countries under study are the United Arab Emirates, Saudi Arabia, Qatar, Bahrain, Kuwait, and Oman. Top 3 Predictions Increased private sector
TARRYTOWN, N.Y. — Siemens Healthineers reported today it has achieved 12 Pre-Market Approvals from the Food and Drug Administration for its infectious disease and oncology testing menu. This milestone means the company’s Atellica® Solution1 now provides laboratories in the U.S. with a comprehensive menu on a single laboratory platform for patients’ in vitro diagnostic testing
